If facial changes during GLP-1 treatment have led you to an estrogen-cream advertisement, ask what the proposed product is supposed to change. Dryness, fine lines, loose skin and reduced facial fullness need different evidence. A study measuring collagen in a skin biopsy cannot establish all of those outcomes.

Seventy volunteers did not mean seventy facial treatments

Rittié and colleagues' 2008 study enrolled 40 postmenopausal women and 30 men, with a mean age of 75 in each group. It investigated topical estradiol and collagen production at different skin sites. Findings in sun-protected hip skin differed from those in sun-damaged skin. [1]

The facial experiment involved five women and five men using 0.2% estradiol cream twice daily for two weeks. Biopsies showed no increase in the measured procollagen markers; blood estradiol concentrations increased in all treated participants. Pfizer partly funded the study, and one author disclosed consulting payments from Pfizer. [1]

This small, short experiment does not establish what longer treatment or another formulation would do. It also does not demonstrate restored facial fat, a lifting effect or benefit specifically during GLP-1 treatment. The research schedule is a description, not an application recommendation. [1]

When an advertisement links to this paper, ask which part supports the advertised outcome. Check whether the reference concerns the face or another body site. Keep a copy of the exact claim with the source so the clinician can address the comparison you are being asked to make.

Write down the hormone and formulation

Estradiol and estriol are different hormones. A paper about estradiol does not automatically validate an estriol product. Ask for the full ingredient list, concentration, formulation and intended application site. If the product combines a hormone with other ingredients, ask what evidence evaluates that combination.

The Endocrine Society notes that compounded preparations can combine hormones with different potencies and that dose and quality inconsistencies have been found in post-market surveys. It advises caution and counseling about non-FDA-approved preparations. Its position addresses compounded hormone therapy generally, rather than providing a trial of a particular facial cream. [2]

Bring all hormone products to the review, including patches, gels, vaginal products and anything ordered through another service. Ask the prescriber to consider the complete regimen. Do not move an existing prescription to a new application site or increase its amount to copy a skincare claim.

Check the approval statement precisely

FDA's menopause information states that compounded “bioidentical” hormones are not FDA-approved. It says there is no evidence that they are safer or more effective than FDA-approved hormone therapy. It also states that no FDA-approved drug contains estriol and that estriol has not been established as a safer form of estrogen. These are U.S. regulatory statements. [3]

FDA also notes that approved drugs can contain hormones identical to those produced by the body. The word “bioidentical” alone therefore does not identify approval status. [3]

Ask whether the exact dispensed product is approved, what condition and route its approval covers, and whether the proposed facial use falls outside that indication. A prescription and a pharmacy name do not answer those separate questions. Ask the clinician why the proposed option fits your concern and what uncertainties remain.

Choose a skin goal you can assess

For menopausal dryness, AAD recommends a mild cleanser and moisturizer, noting that hyaluronic acid or glycerin may help. It recommends a fragrance-free moisturizer for easily irritated skin and dermatology review for persistent dryness or worsening skin conditions. Its advice also includes daily broad-spectrum SPF 30 or higher on uncovered skin. [4]

Describe your concern without replacing it with a product name: “My cheeks feel dry after washing,” “makeup catches on these lines,” or “I notice less fullness here.” Ask which finding the proposed treatment addresses and how improvement would be assessed.

If photographs are useful for follow-up, agree on a method with the clinician. Keep lighting and camera distance similar and avoid filters. Note new products and symptoms separately. A photograph can document a concern; it cannot measure hormone absorption or establish the cause of a facial change.

For the distinction between a topical skin goal and a fuller facial contour, see our guide to firming-cream expectations. A clinician should determine treatment suitability; these sources do not provide an individual hormone regimen.

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.

Sources

  1. Induction of Collagen by Estradiol: Difference Between Sun-Protected and Photodamaged Human Skin In Vivo,2008Rittie and colleagues,Archives of Dermatology↩ Back to text
  2. Compounded Bioidentical Hormone TherapyEndocrine Society↩ Back to text
  3. Menopause: compounded hormones and estriol questionsU.S. Food and Drug Administration↩ Back to text
  4. Caring for your skin in menopauseAmerican Academy of Dermatology↩ Back to text